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Connecticut Inhalation Anthrax Case Confirmed
CDC has confirmed a case of inhalational anthrax in Connecticut. Yesterday CDC was contacted by the 
Connecticut Department of Public Health about a respiratory illness in a 94-year-old female whose blood cultures 
grew organisms identified as Bacillus anthracis. The isolates arrived at CDC last night and were confirmed to be 
B. anthracis early this morning. The patient required intensive care and died this morning.
The investigation in Connecticut is in progress but no source or mechanism of exposure has been identified. 
Persons in the local post office as well as the Wallingford mail processing facility have been advised to initiate 
prophylactic antimicrobial treatment. Additional persons who have visited the patient's home in the past 30 days 
also have been advised to initiate treatment. As the epidemiologic and environmental investigation proceeds, 
updated treatment recommendations will be made.
The Connecticut Department of Public Health is conducting active surveillance to identify additional cases 
suspicious for anthrax. Environmental assessment of the Seymour Post Office and the Wallingford Post Office is 
in progress. In addition, thorough environmental assessments of her home and places she might have visited are 
underway. CDC, FBI, and US Postal Service personnel are collaborating with the Connecticut Department of 
Health in these investigations.
Persons who identify cases of illness suspicious for anthrax are reminded to contact their local health department. 
The CDC Emergency Operations Response Center can be reached at 770 488 7100.









Confirmed 2 5 5 5 1 18
Cutaneous 0 4 3 0 0
Inhalational 2 1 2 5 1
Suspect 0 3 2 0 5
Cutaneous 0 3 2 0
Inhalational 0 0 0 0
As a reminder, CDC confirmed cases are based on a rigorous case definition which was published in CDC's 
Morbidity and Mortality Weekly Report (MMWR) on October 19, 2001. The M MW R is available on-line at: 
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5041a1.htm.
CDC defines a confirmed case of anthrax as 1) a clinically compatible case of cutaneous, inhalational, or 
gastrointestinal illness that is laboratory confirmed by isolation of B. anthracis from an affected tissue or site or 2) 
other laboratory evidence of B. anthracis infection based on at least two supportive laboratory tests. CDC defines 
a suspect case as 1) a clinically compatible case of illness without isolation of B. anthracis and no alternative 
diagnosis, but with laboratory evidence of B. anthracis by one supportive laboratory test or 2) a clinically 
compatible case of anthrax epidemiologically linked to a confirmed environmental exposure, but without 
corroborative laboratory evidence of B. anthracis infection.
For the latest update on CDC activ ities and on-going anthrax investigations visit
www.bt.cdc.gov or www.cdc.gov/od/oc/media
The Centers for Disease Control and Prevention (CDC) protects people's health and safety by preventing and 
controlling diseases and injuries; enhances health decisions by providing credible information on critical health 
issues; and promotes healthy living through strong partnerships with local, national and international
organizations.
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